Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma
Richard B. Wilder, Maria A. Rodriguez, Chul S. Ha, Barbara Pro, Mark A. Hess, Fernando Cabanillas, James D. Cox
Dive into the research topics of 'Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma'. Together they form a unique fingerprint.